Keyphrases
Finland
100%
Population-based
96%
Gastric Cancer
67%
Gastrectomy
62%
Population-based Study
54%
Esophageal Cancer
49%
Postoperative Complications
49%
Esophagogastric Cancer
33%
Anastomotic Leak
30%
National Cohort Study
29%
Gastric Adenocarcinoma
28%
Esophagectomy
28%
Total Gastrectomy
25%
Confidence Interval
24%
Cohort Profile
22%
Post-esophagectomy
22%
5-year Survival
20%
Neoadjuvant Therapy
19%
90-day Mortality
18%
Reoperation
17%
Comorbidity
16%
Hazard Ratio
15%
Consensus Group
14%
Esophageal Complications
14%
Distal Gastrectomy
13%
Gastric Cancer Surgery
13%
Long-term Survival
12%
Odds Ratio
12%
Major Complications
11%
Upfront Surgery
11%
CD4 T Cells
11%
Type 2 Diabetes Mellitus (T2DM)
11%
Gastric Outlet Obstruction
11%
Gastrojejunostomy
11%
Palliative Treatment
11%
Duodenal Stenting
11%
Esophageal Stenting
11%
Thoracoscopic Esophagectomy
11%
Transhiatal
11%
Incidence of Complication
11%
Hemoglobin Count
11%
Neoadjuvant Chemotherapy
11%
Hand-sewn Anastomosis
11%
Anastomosis Leak
11%
Delayed Emptying
11%
Retrospective Survey
11%
Preoperative Hemoglobin
11%
Obesity
11%
Retrocolic Reconstruction
11%
Antecolic
11%
Medicine and Dentistry
Abdominal Cancer
98%
Gastrectomy
75%
Esophagectomy
67%
Postoperative Complication
60%
Stomach Adenocarcinoma
29%
Hazard Ratio
28%
Anastomosis Leakage
28%
Cohort Analysis
26%
Malignant Neoplasm
26%
Esophageal Cancer
25%
Neoadjuvant Therapy
24%
Esophageal Cancer
23%
Stenting
22%
Total Stomach Resection
20%
Reoperation
19%
Comorbidity
19%
Odds Ratio
16%
Symptomatic Treatment
13%
Cancer Surgery
13%
Long Term Survival
12%
Cancer Staging
12%
Partial Gastrectomy
11%
Surgical Anastomosis
11%
Neoadjuvant Chemotherapy
11%
Pylorus Stenosis
11%
Gastrojejunostomy
11%
Thoracic Aorta
11%
T-Helper Cell
11%
Maturity Onset Diabetes of the Young
11%
Adipose Tissue
11%
Splenectomy
11%
Stem Cell
11%
Logistic Regression Analysis
8%
Proportional Hazards Model
7%
Overall Survival
7%
Neoplasm
7%
Retrospective Cohort Study
6%
Tumor Histology
6%
Minimally Invasive Procedure
6%
Mortality Rate
5%
